Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 8/2014

01.08.2014 | Editorial

Attention-deficit/hyperactivity disorder: seeking the right balance between over- and undertreatment

verfasst von: Pieter J. Hoekstra, Andrea Dietrich

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Excerpt

This issue of European Child and Adolescent Psychiatry contains an article that addresses functional impairments associated with subthreshold attention-deficit/hyperactivity disorder (ADHD) [2]. In a Korean nationwide community sample of 921 children, aged 8–11 years, the authors report that children with subthreshold ADHD were found to experience significant functional impairments, i.e., poorer behavioral and emotional control and worse academic performance compared to control children. Subthreshold ADHD was defined by the presence of at least three but no more than five inattentive or hyperactive/impulsive symptoms. However, whereas the diagnostic threshold (≥6/9) for the DSM-IV symptoms represents a clear-cut operationalization for a diagnosis of ADHD, this disregards the fact that for the affected individuals and their parents the relevance of each symptom is likely to be different; for the diagnostic assessment as defined by the DSM-IV the symptoms are merely being counted, without taking the severity of each symptom into account. Furthermore, the subjective and objective impairment due to ADHD symptoms can in theory be greater in a child who fulfills only five symptoms in comparison to a child with six or more symptoms. These considerations illustrate how difficult it is to meaningfully operationalize thresholds for a spectrum disorder such as ADHD. …
Literatur
1.
Zurück zum Zitat Advokat C (2010) What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci Biobehav Rev 34(8):1256–1266PubMedCrossRef Advokat C (2010) What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci Biobehav Rev 34(8):1256–1266PubMedCrossRef
2.
Zurück zum Zitat Hong SB, Dwyer D, Kim JW, Park EJ, Shin MS, Kim BN, Yoo HJ, Cho IH, Bhang SY, Hong YC, Pantelis C, Cho SC Subthreshold attention-deficit/hyperactivity disorder is associated with functional impairments across domains: a comprehensive analysis in a large-scale community study. Eur Child Adolesc Psychiatry (this issue) Hong SB, Dwyer D, Kim JW, Park EJ, Shin MS, Kim BN, Yoo HJ, Cho IH, Bhang SY, Hong YC, Pantelis C, Cho SC Subthreshold attention-deficit/hyperactivity disorder is associated with functional impairments across domains: a comprehensive analysis in a large-scale community study. Eur Child Adolesc Psychiatry (this issue)
3.
Zurück zum Zitat van de Loo-Neus GH, Rommelse N, Buitelaar JK (2011) To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol 21(8):584–599PubMedCrossRef van de Loo-Neus GH, Rommelse N, Buitelaar JK (2011) To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol 21(8):584–599PubMedCrossRef
4.
Zurück zum Zitat McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, Wong IC (2009) Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 194(3):273–277PubMedCrossRef McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, Wong IC (2009) Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 194(3):273–277PubMedCrossRef
5.
Zurück zum Zitat Mikirova NA, Rogers AM, Taylor PR, Hunninghake RE, Miranda-Massari JR, Gonzalez MJ (2013) Metabolic correction for attention deficit/hyperactivity disorder: a biochemical–physiological therapeutic approach. Funct Foods Health Dis 3(1):1–20 Mikirova NA, Rogers AM, Taylor PR, Hunninghake RE, Miranda-Massari JR, Gonzalez MJ (2013) Metabolic correction for attention deficit/hyperactivity disorder: a biochemical–physiological therapeutic approach. Funct Foods Health Dis 3(1):1–20
6.
Zurück zum Zitat Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K (2009) Houck PR; MTA Cooperative Group. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48(5):484–500PubMedCentralPubMedCrossRef Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K (2009) Houck PR; MTA Cooperative Group. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48(5):484–500PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Prasad V, Brogan E, Mulvaney C, Grainge M, Stanton W, Sayal K (2013) How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. Eur Child Adolesc Psychiatry 22(4):203–216PubMedCrossRef Prasad V, Brogan E, Mulvaney C, Grainge M, Stanton W, Sayal K (2013) How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. Eur Child Adolesc Psychiatry 22(4):203–216PubMedCrossRef
8.
Zurück zum Zitat Rommelse N, Buitelaar J (2013) Is there a future for restricted elimination diets in ADHD clinical practice? Eur Child Adolesc Psychiatry 22:199–202PubMedCrossRef Rommelse N, Buitelaar J (2013) Is there a future for restricted elimination diets in ADHD clinical practice? Eur Child Adolesc Psychiatry 22:199–202PubMedCrossRef
9.
Zurück zum Zitat Rucklidge JJ, Kaplan BJ (2013) Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Rev Neurother 13(1):49–73PubMedCrossRef Rucklidge JJ, Kaplan BJ (2013) Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Rev Neurother 13(1):49–73PubMedCrossRef
10.
Zurück zum Zitat Rucklidge JJ, Frampton CM, Gorman B, Boggis A (2014) Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. Br J Psychiatry 204:306–315PubMedCrossRef Rucklidge JJ, Frampton CM, Gorman B, Boggis A (2014) Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. Br J Psychiatry 204:306–315PubMedCrossRef
11.
Zurück zum Zitat Stevenson J, Buitelaar J, Cortese S, Ferrin M, Konofal E, Lecendreux M, Simonoff E, Wong IC, Sonuga-Barke E (2014) Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder—an appraisal of the evidence on efficacy and recommendations on the design of future studies. J Child Psychol Psychiatry 55(5):416–427PubMedCrossRef Stevenson J, Buitelaar J, Cortese S, Ferrin M, Konofal E, Lecendreux M, Simonoff E, Wong IC, Sonuga-Barke E (2014) Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder—an appraisal of the evidence on efficacy and recommendations on the design of future studies. J Child Psychol Psychiatry 55(5):416–427PubMedCrossRef
12.
Zurück zum Zitat Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B (2008) Wigal T; MTA Cooperative Group. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord 12(1):4–14PubMedCrossRef Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B (2008) Wigal T; MTA Cooperative Group. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord 12(1):4–14PubMedCrossRef
Metadaten
Titel
Attention-deficit/hyperactivity disorder: seeking the right balance between over- and undertreatment
verfasst von
Pieter J. Hoekstra
Andrea Dietrich
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 8/2014
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-014-0594-z

Weitere Artikel der Ausgabe 8/2014

European Child & Adolescent Psychiatry 8/2014 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.